TPCW
TD Private Client Wealth Portfolio holdings
AUM
$4.07B
1-Year Return
14.25%
This Quarter Return
+7.42%
1 Year Return
+14.25%
3 Year Return
+49.74%
5 Year Return
+85.19%
10 Year Return
–
AUM
$3.05B
AUM Growth
+$281M
(+10%)
Cap. Flow
+$99.2M
Cap. Flow
% of AUM
3.25%
Top 10 Holdings %
Top 10 Hldgs %
32.37%
Holding
1,279
New
62
Increased
530
Reduced
502
Closed
64
Top Buys
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$5.32M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
$4.55M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$3.31M |
| 4 |
Microsoft
MSFT
|
$3.13M |
| 5 |
iShares MSCI World ETF
URTH
|
$2.74M |
Sector Composition
| 1 | Technology | 8.19% |
| 2 | Financials | 5.38% |
| 3 | Healthcare | 4.84% |
| 4 | Industrials | 3.64% |
| 5 | Consumer Discretionary | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Ameriprise Financial
AMP
$46.5B
| $4.02M | 0.13% |
9,162
-191
| -2% | -$83.7K |
|
127
Vanguard FTSE Emerging Markets ETF
VWO
$96.9B
| $3.95M | 0.13% |
94,568
-21,188
| -18% | -$885K |
|
128
Verisk Analytics
VRSK
$37.7B
| $3.92M | 0.13% |
16,628
-6,820
| -29% | -$1.61M |
|
129
Blackrock
BLK
$169B
| $3.9M | 0.13% |
4,682
+73
| +2% | +$60.9K |
|
130
Gilead Sciences
GILD
$142B
| $3.88M | 0.13% |
52,921
+13,515
| +34% | +$990K |
|
131
iShares Core S&P US Growth ETF
IUSG
$24.6B
| $3.85M | 0.13% |
32,842
+4,570
| +16% | +$536K |
|
132
American Express
AXP
$228B
| $3.76M | 0.12% |
16,522
+2,975
| +22% | +$677K |
|
133
AT&T
T
$211B
| $3.76M | 0.12% |
213,712
+1,137
| +0.5% | +$20K |
|
134
LPL Financial
LPLA
$27.5B
| $3.75M | 0.12% |
14,177
+994
| +8% | +$263K |
|
135
iShares S&P Small-Cap 600 Growth ETF
IJT
$6.26B
| $3.74M | 0.12% |
28,643
-403
| -1% | -$52.7K |
|
136
Analog Devices
ADI
$121B
| $3.73M | 0.12% |
18,879
-5,369
| -22% | -$1.06M |
|
137
Thermo Fisher Scientific
TMO
$186B
| $3.71M | 0.12% |
6,391
+369
| +6% | +$214K |
|
138
LyondellBasell Industries
LYB
$17.4B
| $3.7M | 0.12% |
36,213
-5,982
| -14% | -$612K |
|
139
Abbott
ABT
$232B
| $3.69M | 0.12% |
32,507
+1,808
| +6% | +$205K |
|
140
Exxon Mobil
XOM
$470B
| $3.67M | 0.12% |
31,592
+2,259
| +8% | +$263K |
|
141
Technology Select Sector SPDR Fund
XLK
$83.6B
| $3.6M | 0.12% |
17,303
+2,249
| +15% | +$468K |
|
142
iShares Russell Mid-Cap ETF
IWR
$44.3B
| $3.6M | 0.12% |
42,855
-4,173
| -9% | -$351K |
|
143
Boston Scientific
BSX
$159B
| $3.58M | 0.12% |
52,343
-27,018
| -34% | -$1.85M |
|
144
Vanguard FTSE All-World ex-US ETF
VEU
$48.7B
| $3.5M | 0.11% |
59,644
-7,734
| -11% | -$454K |
|
145
Enbridge
ENB
$105B
| $3.48M | 0.11% |
96,297
-12,807
| -12% | -$463K |
|
146
Bristol-Myers Squibb
BMY
$95.1B
| $3.47M | 0.11% |
64,017
+35,725
| +126% | +$1.94M |
|
147
KKR & Co
KKR
$120B
| $3.38M | 0.11% |
33,622
+33,130
| +6,734% | +$3.33M |
|
148
Micron Technology
MU
$143B
| $3.38M | 0.11% |
28,660
+843
| +3% | +$99.4K |
|
149
Charles River Laboratories
CRL
$8.07B
| $3.32M | 0.11% |
12,249
+2,612
| +27% | +$708K |
|
150
Salesforce
CRM
$237B
| $3.3M | 0.11% |
10,945
+2,955
| +37% | +$890K |
|